What’s the current market cap for Fresenius stock?

Fresenius (FRE) has a market cap of €24bn as of July 04, 2026.

What is the P/E ratio for Fresenius stock?

The price to earnings (P/E) ratio for Fresenius (FRE) stock is 16.23 as of July 04, 2026.

Does Fresenius stock pay dividends?

Yes, the Fresenius (FRE) stock pays dividends to shareholders. As of July 04, 2026, the dividend rate is €1.05 and the yield is 2.48%. Fresenius has a payout ratio of 31.77% on a trailing twelve-month basis.

When is the next Fresenius dividend payment date?

The next Fresenius (FRE) dividend payment date is unconfirmed.

What is the beta indicator for Fresenius?

Fresenius (FRE) has a beta rating of 0.86. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy Fresenius stock | €FRE Share Price

05:30

09:10

12:45

16:25

20:00

About Fresenius

Fresenius SE & Co. KGaA, operating under the ticker FRE, is a global healthcare group founded in 1912. The company specializes in products and services for dialysis, hospitals, and outpatient medical care. Operating in the healthcare sector, Fresenius provides a range of services including engineering and services for hospitals and other healthcare facilities.

Ticker

€FRE

Sector

Health

Primary listing

XETRA

Employees

177,783

Headquarters

Bad Homburg vor der Höhe, Germany

Website

www.fresenius.com

Fresenius Metrics

BasicAdvanced

€24bn

16.23

€2.61

0.86

€1.05

2.48%

What the Analysts think about Fresenius

Analyst ratings (Buy, Hold, Sell) for Fresenius stock.

Bulls say / Bears say

The Biopharma segment delivered 34% organic revenue growth in Q1 2026, driven by the tocilizumab biosimilar Tyenne achieving 40% market share in EU5 and 27% in the United States, underscoring robust product momentum (Reuters via Investing.com)(ca.investing.com)

Adjusted earnings per share rose 13% to €0.82 in Q1 2026, outperforming the company’s full-year EPS growth target of 5–10% and reflecting strong operational leverage (Reuters)(marketscreener.com)

S&P Global Ratings revised Fresenius’ credit outlook from stable to positive in April 2026, affirming the group’s deleveraging progress and resilient free cash flow generation (Fresenius press release)(fresenius.com)

Full-year 2026 organic revenue growth guidance midpoint of 5.5% falls below analysts’ consensus of 5.9%, signaling potential topline underperformance against market expectations (Reuters)(whtc.com)

Guidance for an adjusted operating profit margin of around 11.5% remains flat year-on-year but lags market forecasts of 12.0%, suggesting limited margin expansion in 2026 (Reuters)(whtc.com)

First-quarter 2026 revenue of €5.7 billion missed analysts’ estimates, weighed down by adverse currency translation effects, highlighting sensitivity to exchange-rate headwinds (Reuters)(marketscreener.com)

Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2026.

Fresenius Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

Fresenius Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Market data provided by CBOE Europe and Deutsche Börse.

Bulls say / Bears say

Full-year 2026 organic revenue growth guidance midpoint of 5.5% falls below analysts’ consensus of 5.9%, signaling potential topline underperformance against market expectations (Reuters)(whtc.com)

Guidance for an adjusted operating profit margin of around 11.5% remains flat year-on-year but lags market forecasts of 12.0%, suggesting limited margin expansion in 2026 (Reuters)(whtc.com)

Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2026.

About Fresenius

Ticker

Primary listing

Employees

Fresenius Metrics

Price and volume

Financial strength

Profitability

Management effectiveness

Valuation

Growth

What the Analysts think about Fresenius

Analyst Ratings

Bulls say / Bears say

Fresenius Financial Performance

Income Statement

Fresenius Earnings Performance

Earnings per share (EPS)

Buy €FRE

Lightyear

Legal

Work with us

Bulls say / Bears say

Fresenius/€FRE

About Fresenius

Ticker

Primary listing

Employees

Fresenius Metrics

Price and volume

Financial strength

Profitability

Management effectiveness

Valuation

Growth

What the Analysts think about Fresenius

Analyst Ratings

Bulls say / Bears say

Fresenius Financial Performance

Income Statement

Fresenius Earnings Performance

Earnings per share (EPS)

What’s the current market cap for Fresenius stock?

What is the P/E ratio for Fresenius stock?

Does Fresenius stock pay dividends?

When is the next Fresenius dividend payment date?

What is the beta indicator for Fresenius?

Bulls say / Bears say